Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Smart financial goals help you define clear targets for your money. This intro explains the concept and sets you up with practical steps to start planning today.
18,132 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
IBIT stands at a crossroads as Bitcoin volatility tests its spot-exposure structure. Two signals that will determine ...
The AI infrastructure boom has Nvidia leading, but Alphabet's end-to-end AI stack and TPU ecosystem could reshape the...
HeartFlow and NovoCure represent two very different paths to modernizing care. One targets non invasive CAD diagnosis...
Microsoft’s stock has fallen out of step with broader AI enthusiasm as Copilot results lag and cloud growth cools, le...
The latest data show core PCE at a 9-month high, complicating the Fed’s plan for rate cuts as investors recalibrate b...
New York City Mayor Zohran Mamdani engineered a sweeping primary win, elevating a progressive slate and exposing a cr...
A long standing trading rule is gone, and it could change how millions of small investors trade. This shift may lift ...
The Department of Veterans Affairs rolled out changes to its home loan appraisal process, removing outdated rules and...
The U.S. launches an aircraft strike on Iran after a drone attack on a cargo ship near Hormuz, triggering market vola...
Palvella Therapeutics just saw a notable insider move after a multi-hundred percent rally. This guide breaks down the...
Investing in AI requires more than hype. This guide explains how a Nvidia-backed infrastructure stock hand can unlock...